28.02.2024 – 11:07Helmholtz Zentrum MünchenRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmore
17.10.2022 – 18:21Helmholtz Zentrum MünchenType 1 diabetes: New findings on the development of the autoimmune disease in childrenIDF Websitemore
27.04.2020 – 17:22Helmholtz Zentrum München2Beta cells from stem cells: Potential for cell replacement therapyRead the studymore
